Medicare Enrolled
Dr. John Cozart, MD
Optician · Texarkana, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cozart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cozart?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cozart
Dr. John Cozart is an optician specialist in Texarkana, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Cozart performed 3,464 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cozart received a total of $5,783 from 30 pharmaceutical and/or device companies across 413 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cozart is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 19% volume in TX
$5,783 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,464
Medicare services
Top 19% in TX for optician
Not available
Unique patients (not deduplicated)
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
1,329 | $37 | $92 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
782 | $48 | $122 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
263 | $107 | $804 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
239 | $117 | $261 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
213 | $88 | $156 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
108 | $56 | $700 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
89 | $38 | $94 |
| Tying of multiple internal hemorrhoid groups | 77 | $297 | $742 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
68 | $168 | $1,017 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
65 | $38 | $95 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
44 | $100 | $220 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
39 | $110 | $750 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
36 | $59 | $109 |
| Digestive tract pathogen nucleic acid test, 6-11 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of pathogens in the digestive tract. The test analyzes 6 to 11 specific targets simultaneously. |
22 | $258 | $657 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $136 | $306 |
| Rubber band ligation of internal hemorrhoid A procedure to tie off a single group of internal hemorrhoids using a rubber band to cut off blood supply. |
17 | $247 | $610 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
14 | $33 | $74 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
13 | $80 | $547 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
12 | $10 | $678 |
| Rectal sensitivity and function study A test to evaluate the sensitivity and functional performance of the rectum. |
12 | $212 | $589 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,783
Total received (2018-2024)
Avg $826/year across 7 years
Top 24% in TX for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
413
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$539
2023
$512
2022
$960
2021
$1,642
2020
$670
2019
$806
2018
$655
Payments by company (2024)
ABBVIE INC.
$260
Gilead Sciences, Inc.
$85
PFIZER INC.
$76
Celgene Corporation
$50
Lilly USA, LLC
$20
Mauna Kea Technologies, Inc.
$17
Madrigal Pharmaceuticals
$16
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 78.3% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$1,015
AbbVie Inc.
$844
Janssen Biotech, Inc.
$766
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$620
ABBVIE INC.
$599
Takeda Pharmaceuticals U.S.A., Inc.
$370
PFIZER INC.
$348
AbbVie, Inc.
$307
Allergan Inc.
$177
Celgene Corporation
$89
Braintree Laboratories, Inc.
$79
RedHill Biopharma Inc.
$70
Ironwood Pharmaceuticals, Inc
$67
EVOKE PHARMA, INC.
$50
Mauna Kea Technologies, Inc.
$39
Boston Scientific Corporation
$35
GENZYME CORPORATION
$32
Amgen Inc.
$31
Merck Sharp & Dohme Corporation
$27
INTERCEPT PHARMACEUTICALS, INC.
$26
Merck Sharp & Dohme LLC
$26
UCB, Inc.
$25
Nestle HealthCare Nutrition Inc.
$22
Myriad Genetic Laboratories, Inc.
$21
Lilly USA, LLC
$20
Medtronic, Inc.
$19
Prometheus Laboratories Inc.
$18
Madrigal Pharmaceuticals
$16
Allergan, Inc.
$12
Organon LLC
$12
Top 3 companies account for 45.4% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Amitiza · BYVALSON · CAPTIVATOR COLD · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · Entyvio · GI Genius · GIMOTI · HUMIRA · Humira · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · OCALIVA · OMVOH · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUPREP · SUPREP BOWEL PREP · SUTAB · TRULANCE · Talicia · UCERIS TABLETS · VIBERZI · XELJANZ · XIFAXAN · ZENPEP · ZEPATIER · ZEPOSIA · myRisk · talicia
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
24
County median income
$59,295
Nearest hospital to ZIP centroid (approximate)
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cozart is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cozart experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Cozart performed 1,329 chronic care management, additional 20 min/month services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cozart receive payments from pharmaceutical companies?
Yes. Dr. Cozart received a total of $5,783 from 30 companies across 413 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cozart's costs compare to other opticians in Texarkana?
Dr. Cozart's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cozart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Texarkana
Browse opticians in Texarkana ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology